The pharma industry has had a year to address MHRA’s April 2014 update to the definition of a critical GCP inspection finding to include trial master files(TMFs) that are “not readily available or accessible”. How has it fared? Rik van Mol reports.
Technology
Latest News
Advertisement
Advertisement
July 23, 2015.
July 22, 2015.
21 July, 2015.
July 21, 2015.
Pharmaceutical Executive
Lisa Henderson discusses how role of social media in post-market adverse event reporting is finally being taken seriously by the FDA.
20 July, 2015.
July 17, 2015.
A quick countdown of this year's Top 50 movers and shakers.
July 15, 2015.
July 15, 2015.
July 14, 2015.
The European Medicines Agency (EMA) has started a review of human papillomavirus (HPV) vaccines to further clarify aspects of their safety profile.HPVvaccines have been used in around 72 million people worldwide to prevent cervical cancer and other cancers and conditions caused by HPV. Cervical cancer is the fourth most common cause of cancer death in women worldwide.
July 10, 2015.
All indications are that the July 2016 deadline for transition from Europe's eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) to the new Identification of Medicinal Products (IDMP) is not achievable. Sophie Daniels reports.
July 9, 2015.
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
3
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science
4
FDA Sends Warning Letter to ImmunityBio for Misleading Claims in Advertisement
5